Endothelial progenitor cells as potential drug targets

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 5, Issue 4, 2005, Pages 277-286

  Thum, T ^a   Bauersachs, J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Coronary artery disease; Diabetes; Drug treatment; Endothelial progenitor cells; Mobilisation; Myocardial infarction; Statins

Indexed keywords

ANGIOPOIETIN 1; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; CARDIOVASCULAR AGENT; CELL MARKER; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ESTROGEN; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEMANGIOPOIETIN; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR CC; ROSIGLITAZONE; SCATTER FACTOR; SECRETONEURIN; SIMVASTATIN; STROMAL CELL DERIVED FACTOR 1; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ARTERY DISEASE; ATHEROSCLEROSIS; BONE MARROW CELL; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIUM PROGENITOR CELL; GENE TRANSFER; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VALVE PROSTHESIS; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; PROGNOSIS; REVIEW; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION;

EID: 23644450083     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006054553435     Document Type: Review

References (106)

1. Wollert, K.C., Drexler, H. Clinical applications of stem cells for the heart. Circ. Res., 2005, 96, 151-63.
2. Galinanes, M., Loubani, M., Davies, J., Chin, D., Pasi, J., Bell, P.R. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell. Transplant, 2004, 13, 7-13.
3. Deten, A., Volz, H.C., Clamors, S., Leiblein, S., Briest, W., Marx, G., Zimmer, H.G. Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc. Res., 2005, 65, 52-63.
4. Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rutten, H., Fichtlscherer, S., Martin, H., Zeiher, A.M. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest., 2001, 108, 391-7.
5. Min, T.Q., Zhu, C.J., Xiang, W.X., Hui, Z.J., Peng, S.Y. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther., 2004, 18, 203-9.
6. Bahlmann, F.H., de Groot, K., Mueller, O., Hertel, B., Haller, H., Fliser, D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension, 2005, 45, 526-9.
7. Skowasch, D., Jabs, A., Andrie, R., Dinkelbach, S., Luderitz, B., Bauriedel, G. Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Cardiovasc. Res., 2003, 60, 684-91.
8. Hu, Y., Davison, F., Zhang, Z., Xu, Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation, 2003, 108, 3122-7.
9. Hilbe, W., Dirnhofer, S., Oberwasserlechner, F., Schmid, T., Gunsilius, E., Hilbe, G., Woll, E., Kahler, C.M. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J. Clin. Pathol., 2004, 57, 965-9.
10. Cohnheim, J. Über Entzündung und Eiterung [About inflammation and sepsis]. Pathol. Anat. Physiol. Clin. Med., 1867, 40, 1-79.
11. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275, 964-7.
12. Cho, H.J., Kim, H.S., Lee, M.M., Kim, D.H., Yang, H.J., Hur, J., Hwang, K.K., Oh, S., Choi, Y.J., Chae, I.H., Oh, B.H., Choi, Y.S., Walsh, K., Park, Y.B. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation, 2003, 108, 2918-25.
13. Khakoo, A.Y., Finkel, T. Endothelial progenitor cells. Annu. Rev. Med., 2005, 56, 79-101.
14. Assmus, B., Schachinger, V., Teupe, C., Britten, M., Lehmann, R., Dobert, N., Grunwald, F., Aicher, A., Urbich, C., Martin, H., Hoelzer, D., Dimmeler, S., Zeiher, A.M. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation, 2002, 106, 3009-17.
15. Rafii, S., Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med., 2003, 9, 702-12.
16. Stamm, C., Westphal, B., Kleine, H.D. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet, 2003, 361, 45-6.
17. Schachinger, V., Assmus, B., Britten, M.B., Honold, J., Lehmann, R., Teupe, C., Abolmaali, N.D., Vogl, T.J., Hofmann, W.K., Martin, H., Dimmeler, S., Zeiher, A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol., 2004, 44, 1690-9.
18. Wollert, K.C., Meyer, G.P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., Arseniev, L., Hertenstein, B., Ganser, A., Drexler, H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 2004, 36, 141-8.
19. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., Amano, K., Kishimoto, Y., Yoshimoto, K., Akashi, H., Shimada, K., Iwasaka, T., Imaizumi, T. Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet, 2002, 360, 427-35.
20. Perin, E. Transendocardial injection of autologous mononuclear bone marrow cells in end-stage ischemic heart failure patients: one-year follow-up. Int. J. Cardiol., 2004, 95, S45-6.
21. Zhao, Y.D., Courtman, D.W., Deng, Y., Kugathasan, L., Zhang, Q., Stewart, D.J. Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow-Derived Endothelial-Like Progenitor Cells. Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease. Circ. Res., 2005, Feb 3, [Epub ahead of print]
22. Kang, H.J., Kim, H.S., Zhang, S.Y., Park, K.W., Cho, H.J., Koo, B.K., Kim, Y.J., Soo, Lee. D, Sohn, D.W., Han, K.S., Oh, B.H., Lee, M.M., Park, Y.B. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet, 2004, 363, 751-6.
23. Kong, D., Melo, L.G., Gnecchi, M., Zhang, L., Mostoslavsky, G., Liew, C.C., Pratt, R.E., Dzau, V.J. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation, 2004, 110, 2039-46.
24. Yoon, Y.S., Park, J.S., Tkebuchava, T., Luedeman, C., Losordo, D.W. Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial Infarction. Circulation, 2004, 109, 3154-7.
25. Choi, J.H., Kim, K.L., Huh, W., Kim, B., Byun, J., Suh, W., Sung, J., Jeon, E.S., Oh, H.Y., Kim, D.K. Decreased Number and Impaired Angiogenic Function of Endothelial Progenitor Cells in Patients With Chronic Renal Failure. Arterioscler Thromb. Vasc. Biol., 2004, 24, 1246-52.
26. Eizawa, T., Ikeda, U., Murakami, Y., Matsui, K., Yoshioka, T., Takahashi, M., Muroi, K., Shimada, K. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart, 2004, 90, 685-6.
27. Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H., Martin, H., Zeiher, A.M., Dimmeler, S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 2004, 109:1615-22.
28. Grisar, J., Aletaha, D., Steiner, C.W., Kapral, T., Steiner, S., Seidinger, D., Weigel, G., Schwarzinger, I., Wolozcszuk, W., Steiner, G., Smolen, J.S. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation, 2005, 111, 204-11.
29. Thum, T., Tsikas, T., Stein, S., Schultheiss, M., Eigenthaler, M., Anker, S.D., Poole-Wilson, P.A., Ertl, G. and Bauersachs, J. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J. Am. Coll. Cardiol., 2005 (in press).
30. George, J., Goldstein, E., Abashidze, S., Deutsch, V., Shmilovich, H., Finkelstein, A., Herz, I., Miller, H., Keren, G. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur. Heart J., 2004, 25, 1003-8.
31. George, J., Herz,. I, Goldstein, E., Abashidze, S., Deutch, V., Finkelstein, A., Michowitz, Y., Miller, H., Keren, G. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 57-60.
32. Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A., Sasaki, K., Shimada, T., Oike, Y., Imaizumi, T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 2004, 103, 2776-9.
33. Nygren, J.M., Jovinge, S., Breitbach, M., Sawen, P., Roll, W., Hescheler, J., Taneera, J., Fleischmann, B.K., Jacobsen, S.E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med., 2004, 10, 494-501.
34. Valgimigli, M., Rigolin, G.M., Fucili, A., Porta, M.D., Soukhomovskaia, O., Malagutti, P., Bugli, A.M., Bragotti, L.Z., Francolini, G., Mauro, E., Castoldi, G., Ferrari, R. CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure. Circulation, 2004, 110, 1209-12.
35. De Groot, K., Bahlmann, F.H., Sowa, J., Koenig, J., Menne, J., Haller, H., Fliser, D. Uremia causes endothelial progenitor cell deficiency. Kidney Int., 2004, 66, 641-6.
36. Loomans, C.J., de Koning, E.J., Staal, F.J., Rookmaaker, M.B., Verseyden, C., de Boer, H.C., Verhaar, M.C., Braam, B., Rabelink, T.J., van Zonneveld, A.J. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 2004, 53, 195-9.
37. Tepper, O.M., Galiano, R.D., Capla, J.M., Kalka, C., Gagne, P.J., Jacobowitz, G.R., Levine, J.P., Gurtner, G.C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 2002, 106, 2781-6.
38. Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jurgens, K., Miche, E., Bohm, M., Nickenig, G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation, 2004, 109, 220-6.
39. Op, Den Buijs J., Musters, M., Verrips, T., Post, J.A., Braam, B., Van, Riel N. Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing and telomere shortening. Am. J. Physiol. Heart Circ. Physiol., 2004, 287, 2651-8.
40. Assmus, B., Urbich, C., Aicher, A., Hofmann, W.K., Haendeler, J., Rossig, L., Spyridopoulos, I., Zeiher, A.M., Dimmeler, S. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ. Res., 2003, 92, 1049-55.
41. Dernbach, E., Urbich, C., Brandes, R.P., Hofmann, W.K., Zeiher, A.M., Dimmeler, S. Anti-oxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood, 2004, 104, 3591-7.
42. Zhong, T.P., Rosenberg, M., Mohideen, M.A., Weinstein, B., Fishman, M.C. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science, 2004, 287, 1820-4.
43. Chi, J.T., Chang, H.Y., Haraldsen, G., Jahnsen, F.L., Troyanskaya, O.G., Chang, D.S., Wang, Z., Rockson, S.G., van de Rijn, M., Botstein, D., Brown, P.O. Endothelial cell diversity revealed by global expression profiling. Proc. Natl. Acad. Sci. USA, 2003, 100, 10623-8.
44. Koyanagi, M., Haendeler, J., Badorff, C., Brandes, R.P., Hoffmann, J., Pandur, P., Zeiher, A.M., Kuhl, M., Dimmeler, S. Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J. Biol. Chem., 2005 Feb 8 [Epub ahead of print]
45. Dimmeler, S., Vasa-Nicotera, M. Aging of progenitor cells: limitation for regenerative capacity? J. Am. Coll. Cardiol., 2003, 42, 2081-2.
46. Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., Finkel, T.Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med., 2003, 348, 593-600.
47. Scheubel, R.J., Zorn, H., Silber, R.E., Kuss, O., Morawietz, H., Holtz, J., Simm, A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol. 2003, 42, 2073-80.
48. Rauscher, F.M., Goldschmidt-Clermont, P.J., Davis, B.H., Wang, T., Gregg, D., Ramaswami, P., Pippen, A.M., Annex, B.H., Dong, C., Taylor, D.A. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation, 2003, 108, 457-63.
49. Harley, C.B., Futcher, A.B., Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature, 1990, 345, 458-60.
50. Thum, T., Haverich, A., Borlak, J. Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology. FASEB J., 2000, 14, 740-51.
51. Scalera, F., Borlak, J., Beckmann, B., Martens-Lobenhoffer, J., Thum, T., Frolich, J.C., Bode-Boger, S.M. Endogenous NO-synthesis inhibitor asymmetric dimethyl L-arginine (ADMA) accelerates endothelial cell senescence. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 1816-22.
52. Brandes, R.P., Fleming, I., Busse, R. Endothelial aging. Cardiovasc. Res., 2005, 66, 286-94.
53. Nakamura, T.M., Morin, G.B., Chapman, K.B. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997, 277, 955-9.
54. Greider, C.W., Blackburn, E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 1985, 43, 405-13.
55. Campisi, J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol., 2001, 11, S27-31.
56. Sato, I., Morita, I., Kaji, K., Ikeda, M., Nagao, M., Murota, S. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endotheliall cell. Biochem. Biophys. Res. Commun., 1993, 195, 1070-6.
57. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q., Bacchetti, S., Haber, D.A., Weinberg, R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 1997, 90, 785-95.
58. Murasawa, S., Llevadot, J., Silver, M., Isner, J.M., Losordo, D.W., Asahara, T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation, 2002, 106, 1133-9.
59. Bruhl, T., Heeschen, C., Aicher, A., Jadidi, A.S., Haendeler, J., Hoffmann, J., Schneider, M.D., Zeiher, A.M., Dimmeler, S., Rossig, L. p21Cip1 levels differentially regulate turnover of mature endothelial cells, endothelial progenitor cells, and in vivo neovascularization. Circ. Res., 2004, 94, 686-92.
60. Kawamoto, A., Murayama, T., Kusano, K., Ii, M., Tkebuchava, T., Shintani, S., Iwakura, A., Johnson, I., von Samson, P., Hanley, A., Gavin, M., Curry, C., Silver, M., Ma, H., Kearney, M., Losordo, D.W. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation, 2004, 110, 1398-405.
61. Landmesser, U., Engberding, N., Bahlmann, F.H., Schaefer, A., Wiencke, A., Heineke, A., Spickermann, S., Hilfiker-Kleiner, D., Templin, C., Kotlarz, D., Mueller, M., Fuchs, M., Hornig, B., Haller, H., Drexler, H. Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide Synthase. Circulation, 2004, 110, 1933-9.
62. Vasa, M., Fichtlscherer, S., Adler, K., Aicher, A., Martin, H., Zeiher, A.M., Dimmeler, S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 2001, 103, 2885-90.
63. Walter, D.H., Zeiher, A.M., Dimmeler, S. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. Coron. Artery Dis., 2004, 15, 235-42.
64. Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-Ihling, K., Zeiber, A.M., Dimmeler, S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med., 2003, 9, 1370-6.
65. Weis, M., Heeschen, C., Glassford, A.J., Cooke, J.P. Statins have biphasic effects on angiogenesis. Circulation, 2002, 105, 739-45.
66. Spyridopoulos, I., Haendeler, J., Urbich, C., Brummendorf, T.H., Oh, H., Schneider, M.D., Zeiher, A.M., Dimmeler, S. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation, 2004, 110, 3136-42.
67. He, T., Peterson, T.E., Holmuhamedov, E.L., Terzic, A., Caplice, N.M., Oberley, L.W., Katusic, Z.S. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 2021-7.
68. Hornig, B., Landmesser, U., Kohler, C., Ahlersmann, D., Spiekermann, S., Christoph, A., Tatge, H., Drexler, H. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation, 2001, 103, 799-805.
69. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N.R., Crystal, R.G., Besmer, P., Lyden, D., Moore, M.A., Werb, Z., Rafii, S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 2002, 109, 625-37.
70. Tanimura, S., Asato, K., Fujishiro, S.H., Kohno, M. Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44. Biochem. Biophys. Res. Commun., 2003, 304, 801-6.
71. Ma, Z., Shah, R.C., Chang, M.J., Benveniste, E.N. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol., 2004, 24, 5496-509.
72. Moon, S.K., Cha, B.Y., Kim, C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J. Cell. Physiol., 2004, 198, 417-27.
73. Chung, T.W., Lee, Y.C., Kim, C.H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J., 2004, 18, 1123-5.
74. Bahlmann, F.H., de Groot, K., Mueller, O., Hertel, B., Haller, H., Fliser, D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension, 2005, 45, 526-9.
75. Wang, C.H., Ciliberti, N., Li, S.H., Szmitko, P.E., Weisel, R.D., Fedak, P.W., Al-Omran, M., Cherng, W.J., Li, R.K., Stanford, W.L., Verma, S. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation, 2004, 109, 1392-400.
76. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J.M., Asahara, T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med., 1999, 5, 434-8.
77. Powell, T.M., Paul, J.D., Hill, J.M., Thompson, M., Benjamin, M., Rodrigo, M., McCoy, J.P., Read, E.J., Khuu, H.M., Leitman, S.F., Finkel, T., Cannon, R.O. 3rd. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 296-301.
78. Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., Mildner-Rihm, C., Martin, H., Zeiher, A.M., Dimmeler, S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood, 2003, 102, 1340-6.
79. Bahlmann, F.H., De Groot, K., Spandau, J.M., Landry, A.L., Hertel, B., Duckert, T., Boehm, S.M., Menne, J., Haller, H., Fliser, D. Erythropoietin regulates endothelial progenitor cells. Blood, 2004, 103, 921-6.
80. Parsa, C.J., Matsumoto, A., Kim, J., Riel, R.U., Pascal, L.S., Walton, G.B., Thompson, R.B., Petrofski, J.A., Annex, B.H., Stamler, J.S., Koch, W.J. A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest., 2003, 112, 999-1007.
81. Liu, Y.J., Lu, S.H., Xu, B., Yang, R.C., Ren, Q., Liu, B., Li, B., Lu, M., Yan, F.Y., Han, Z.B., Han, Z.C. Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages. Blood, 2004, 103, 4449-56.
82. Kirchmair, R., Egger, M., Walter, D.H., Eisterer, W., Niederwanger, A., Woell, E., Nagl, M., Pedrini, M., Murayama, T., Frauscher, S., Hanley, A., Silver, M., Brodmann, M., Sturm, W., Fischer-Colbrie, R., Losordo, D.W., Patsch, J.R., Schratzberger, P. Secretoneurin, an angiogenic neuropeptide, induces postnatal vasculogenesis. Circulation, 2004, 110, 1121-7.
83. Zhang, J., Lu, S.H., Liu, Y.J., Feng, Y., Han, Z.C. Platelet factor 4 enhances the adhesion of normal and leukemic hematopoietic stem/progenitor cells to endothelial cells. Leuk. Res., 2004, 28, 631-8.
84. Abbott, J.D., Huang, Y., Liu, D., Hickey, R., Krause, D.S., Giordano, F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 2004, 110, 3300-5.
85. Ceradini, D.J., Kulkarni, A.R., Callaghan, M.J., Tepper, O.M., Bastidas, N., Kleinman, M.E., Capla, J.M., Galiano, R.D., Levine, J.P., Gurtner, G.C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med., 2004, 10, 858-64.
86. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M., Reme, C.E. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retina degeneration. Nat. Med., 2002, 8, 718-24.
87. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., Isner, J.M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J., 1999, 18, 3964-72.
88. Fukuda, S., Kaga, S., Sasaki, H., Zhan, L., Zhu, L., Otani, H., Kalfin, R., Das, D.K., Maulik, N. Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J. Mol. Cell Cardiol., 2004, 36, 547-59.
89. Young, P.P., Hofling, A.A., Sands, M.S. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 11951-6.
90. Li, X., Tjwa, M., Moons, L., Fons, P., Noel, A., Ny, A., Zhou, J.M., Lennartsson, J., Li, H., Luttun, A., Ponten, A., Devy, L., Bouche, A., Oh, H., Manderveld, A., Blacher, S., Communi, D., Savi, P., Bono, F., Dewerchin, M., Foidart, J.M., Autiero, M., Herbert, J.M., Collen, D., Heldin, C.H., Eriksson, U., Carmeliet, P. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J. Clin. Invest., 2005, 115, 118-27.
91. Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D.J., Zhu, Z., Bohlen, P., Witte, L., Hendrikx, J., Hackett, N.R., Crystal, R.G., Moore, M.A., Werb, Z., Lyden, D., Rafii, S. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med., 2002, 8, 841-9.
92. Tamarat, R., Silvestre, J.S., Le Ricousse-Roussanne, S., Barateau, V., Lecomte-Raclet, L., Clergue, M., Duriez, M., Tobelem, G., Levy, B.I. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am. J. Pathol., 2004, 164, 457-66.
93. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Suzuki T, Mizuno S, Nakamura T, Sasaki H. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem. Biophys. Res. Commun., 2004, 324, 276-80.
94. Hattori, K., Dias, S., Heissig, B., Hackett, N.R., Lyden, D., Tateno, M., Hicklin, D.J., Zhu, Z., Witte, L., Crystal, R.G., Moore, M.A., Rafii, S. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med., 2001, 193, 1005-1014
95. Burger, P.E., Coetzee, S., McKeehan, W.L., Kan, M., Cook, P., Fan, Y., Suda, T., Hebbel, R.P., Novitzky, N., Muller, W.A., Wilson, E.L. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood, 2002, 100, 3527-35.
96. Prorock, A.J., Hafezi-Moghadam, A., Laubach, V.E., Liao, J.K., Ley, K. Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. Am. J. Physiol. Heart Circ. Physiol., 2003, 284, 133-40.
97. Strehlow, K., Werner, N., Berweiler, J., Link, A., Dirnagl, U., Priller, J., Laufs, K., Ghaeni, L., Milosevic, M., Bohm, M., Nickenig, G. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation, 2003, 107, 3059-65.
98. Iwakura, A., Luedemann, C., Shastry, S., Hanley, A., Kearney, M., Aikawa, R., Isner, J.M., Asahara, T., Losordo, D.W. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation, 2003, 108, 3115-21.
99. Powell, T.M., Paul, J.D., Hill, J.M., Thompson, M., Benjamin, M., Rodrigo, M., McCoy, J.P., Read, E.J., Khuu, H.M., Leitman, S.F., Finkel, T., Cannon, R.O. 3rd. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 296-301.
100. Iwaguro, H., Yamaguchi, J., Kalka, C., Murasawa, S., Masuda, H., Hayashi, S., Silver, M., Li, T., Isner, J.M., Asahara, T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation, 2002, 105, 732-8.
101. Choi, J.H., Hur, J., Yoon, C.H., Kim, J.H., Lee, C.S., Youn, S.W., Oh, I.Y., Skurk, C., Murohara, T., Park, Y.B., Walsh, K., Kim, H.S. Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J. Biol. Chem., 2004, 279, 49430-8.
102. Zhu, J.H., Tao, Q.M., Chen, J.Z., Wang, X.X., Zhu, J.H., Shang, Y.P. Statins contribute to enhancement of the number and the function of endothelial progenitor cells from peripheral blood. Sheng Li Xue Bao, 2004, 56, 357-64.
103. Yamaguchi, J., Kusano, K.F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch-Marce, M., Masuda, H., Losordo, D.W., Isner, J.M., Asahara, T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation, 2003, 107, 1322-8.
104. Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H., Kawamoto, A., Walsh, K., Isner, J.M., Asahara, T. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J. Clin. Invest., 2001, 108, 399-405.
105. Walter, D.H., Rittig, K., Bahlmann, F.H., Kirchmair, R., Silver, M., Murayama, T., Nishimura, H., Losordo, D.W., Asahara, T., Isner, J.M. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation, 2002, 105, 3017-24.
106. Hristov, M. Weber, C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell Mol. Med., 2004, 8, 498-508.